인쇄하기
취소
|
The conflict between the pharmaceutical distribution industry and Pfizer Korea over distribution cost has begun.
The pharmaceutical distribution industry, after the accomplishment of distribution cost raise with GSK in this early October, has sent official memos to request multinational pharmaceutical companies for reasonable distribution cost at a level of the break-even point.
It has drawn ...